May 6 |
Y-mAbs Therapeutics Q1 2024 Earnings Preview
|
Apr 26 |
Y-mAbs to Announce First Quarter 2024 Financial and Operating Results on May 7, 2024
|
Apr 25 |
Y-mAbs to Present at 2024 ASCO Annual Meeting
|
Apr 18 |
Y-mAbs Therapeutics (NASDAQ:YMAB) rises 9.6% this week, taking one-year gains to 161%
|
Mar 28 |
Wall Street Analysts Think YmAbs Therapeutics (YMAB) Could Surge 31.33%: Read This Before Placing a Bet
|
Mar 20 |
YmAbs Therapeutics (YMAB) Surges 8.2%: Is This an Indication of Further Gains?
|
Mar 14 |
Y-mAbs Therapeutics says CFO Kruse will resign from his role
|
Mar 14 |
Y-mAbs Therapeutics Announces Resignation of Chief Financial Officer
|
Mar 12 |
Wall Street Analysts See a 31.41% Upside in Y-mAbs Therapeutics, Inc. (YMAB): Can the Stock Really Move This High?
|
Mar 6 |
Cracking The Code: Understanding Analyst Reviews For Y-mAbs Therapeutics
|